Drug Shortage Report for RAPAFLO

Last updated on 2018-09-25 History
Report ID 56121
Drug Identification Number 02361663
Brand name RAPAFLO
Common or Proper name Rapaflo
Company Name ALLERGAN INC
Active Ingredient(s) SILODOSIN
Strength(s) 4MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30 cap bottle
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-07-06
Estimated end date 2018-08-10
Actual end date 2018-09-03
Shortage status Resolved
Updated date 2018-09-25
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-09-25 French Compare
v3 2018-09-25 English Compare
v2 2018-07-20 French Compare
v1 2018-07-20 English Compare